beta cell protecting and immunomodulatory activities of Paecilomyces Hepiali Chen mycelium in STZ induced T1DM mice.
暂无分享,去创建一个
M. Xiang | Jing Tang | Xiao-lei Zou | S. Xie | Yun-yang Wang | Zeng-Yu Zhao
[1] C. Bochmann,et al. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings. , 2009, Experimental and clinical endocrinology.
[2] F. Nicoletti,et al. A Potent Immunomodulatory Compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxasole Acetic Acid, Prevents Spontaneous and Accelerated Forms of Autoimmune Diabetes in NOD Mice and Inhibits the Immunoinflammatory Diabetes Induced by Multiple Low Doses of Streptozotocin in CBA/H Mice , 2007, Journal of Pharmacology and Experimental Therapeutics.
[3] I. Yaniv,et al. Pancreatic islets under attack: cellular and molecular effectors. , 2007, Current pharmaceutical design.
[4] L. Chatenoud. Protection from autoimmunity: Immunological indifference versus T‐cell mediated suppression? , 2006, European journal of immunology.
[5] T. Ng,et al. Pharmacological actions of Cordyceps, a prized folk medicine , 2005, The Journal of pharmacy and pharmacology.
[6] Cherng Jong-Yuh,et al. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. , 2005, Life sciences.
[7] R. Gao,et al. [Clinical study on application of bailing capsule after renal transplantation]. , 2004, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[8] K. Ha,et al. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. , 2003, Toxicology and applied pharmacology.
[9] Meng Chen,et al. The Novel Anti-inflammatory Compound, Lisofylline, Prevents Diabetes in Multiple Low-Dose Streptozotocin-Treated Mice , 2003, Pancreas.
[10] V. Trajković,et al. Down‐regulation of multiple low dose streptozotocin‐induced diabetes by mycophenolate mofetil , 2002, Clinical and experimental immunology.
[11] Yuehong Wu,et al. Increased Entry into the IFN-γ Effector Pathway by CD4+ T Cells Selected by I-Ag7 on a Nonobese Diabetic Versus C57BL/6 Genetic Background1 , 2001, The Journal of Immunology.
[12] D. Harlan,et al. Low Dose Streptozotocin-Induced Diabetes in Rat Insulin Promoter-mCD80-Transgenic Mice Is T Cell Autoantigen-Specific and CD28 Dependent1 2 , 2001, The Journal of Immunology.
[13] D. Altmann,et al. Streptozotocin‐induced diabetes in mice lacking αβ T cells , 1997 .
[14] S. Usui,et al. Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. , 1996, Biological & pharmaceutical bulletin.
[15] D. Yin,et al. [Advances in the study on artificial cultivation of Cordyceps sinensis]. , 1995, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[16] M. Matsumoto,et al. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice , 1992, European journal of immunology.
[17] Ukai,et al. Polysaccharides in fungi. XXX. Antitumor and immunomodulating activities of two polysaccharides from the fruiting bodies of Armillariella tabescens. , 1992, Chemical & pharmaceutical bulletin.
[18] H. Kolb,et al. Low-Dose Streptozocin-Induced Diabetes in Mice: Electron Microscopy Reveals Single-Cell Insulitis Before Diabetes Onset , 1988, Diabetes.
[19] H. Kolb,et al. Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes. , 1987, Diabetes research.
[20] Zou Xiao-lei. Hypoglycemic effect and mechanism study on streptozocin induced diabetes in mice by Paecilomyces hepiali Chen Mycelium , 2006 .
[21] L. J. L. D. van Griensven,et al. Science and cultivation of edible fungi. , 2000 .
[22] R. Rajotte,et al. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. , 1999, Diabetes.
[23] M. Lukic,et al. Effector Mechanisms in Low-Dose Streptozotocin-induced Diabetes , 1998, Developmental immunology.